LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 2 | M06 | 72 | hr | 868 | 3823 | 3486 | 1.0965 | 1.1286 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 3 | M06 | 72 | hr | 868 | 3838 | 3486 | 1.1008 | 1.1343 |
MDA-MB-231 | WH-4-025 | 0.04 | uM | LJP5 | 1 | O12 | 72 | hr | 868 | 2739 | 3486 | 0.7856 | 0.7146 |
MDA-MB-231 | WH-4-025 | 0.04 | uM | LJP5 | 2 | O12 | 72 | hr | 868 | 2946 | 3486 | 0.8450 | 0.7936 |
MDA-MB-231 | WH-4-025 | 0.04 | uM | LJP5 | 3 | O12 | 72 | hr | 868 | 2781 | 3486 | 0.7977 | 0.7306 |
MDA-MB-231 | WZ-4-145 | 0.04 | uM | LJP6 | 1 | J24 | 72 | hr | 868 | 2717 | 3486 | 0.7793 | 0.7061 |
MDA-MB-231 | WZ-4-145 | 0.04 | uM | LJP6 | 2 | J24 | 72 | hr | 868 | 2685 | 3486 | 0.7701 | 0.6939 |
MDA-MB-231 | WZ-4-145 | 0.04 | uM | LJP6 | 3 | J24 | 72 | hr | 868 | 2558 | 3486 | 0.7337 | 0.6454 |
MDA-MB-231 | XMD16-144 | 0.04 | uM | LJP5 | 1 | M12 | 72 | hr | 868 | 1648 | 3486 | 0.4727 | 0.2979 |
MDA-MB-231 | XMD16-144 | 0.04 | uM | LJP5 | 2 | M12 | 72 | hr | 868 | 1841 | 3486 | 0.5281 | 0.3716 |
MDA-MB-231 | XMD16-144 | 0.04 | uM | LJP5 | 3 | M12 | 72 | hr | 868 | 1654 | 3486 | 0.4744 | 0.3002 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 1 | P18 | 72 | hr | 868 | 2503 | 3486 | 0.7179 | 0.6244 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 2 | P18 | 72 | hr | 868 | 3153 | 3486 | 0.9044 | 0.8727 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 3 | P18 | 72 | hr | 868 | 2867 | 3486 | 0.8223 | 0.7634 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 868 | 3578 | 3486 | 1.0263 | 1.0350 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 2 | H06 | 72 | hr | 868 | 3954 | 3486 | 1.1341 | 1.1786 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 3 | H06 | 72 | hr | 868 | 3957 | 3486 | 1.1350 | 1.1797 |
MDA-MB-231 | BX-912 | 0.04 | uM | LJP5 | 1 | L24 | 72 | hr | 868 | 2821 | 3486 | 0.8091 | 0.7459 |
MDA-MB-231 | BX-912 | 0.04 | uM | LJP5 | 2 | L24 | 72 | hr | 868 | 3347 | 3486 | 0.9600 | 0.9468 |
MDA-MB-231 | BX-912 | 0.04 | uM | LJP5 | 3 | L24 | 72 | hr | 868 | 3034 | 3486 | 0.8702 | 0.8272 |
MDA-MB-231 | Canertinib | 0.04 | uM | LJP6 | 1 | H12 | 72 | hr | 868 | 3518 | 3486 | 1.0091 | 1.0121 |
MDA-MB-231 | Canertinib | 0.04 | uM | LJP6 | 2 | H12 | 72 | hr | 868 | 3910 | 3486 | 1.1215 | 1.1618 |
MDA-MB-231 | Canertinib | 0.04 | uM | LJP6 | 3 | H12 | 72 | hr | 868 | 4066 | 3486 | 1.1662 | 1.2214 |
MDA-MB-231 | Celastrol | 0.04 | uM | LJP6 | 1 | G12 | 72 | hr | 868 | 3666 | 3486 | 1.0515 | 1.0686 |
MDA-MB-231 | Celastrol | 0.04 | uM | LJP6 | 2 | G12 | 72 | hr | 868 | 3462 | 3486 | 0.9930 | 0.9907 |